Programme Titles Presenters
Thursday, September 27, 2018
12:00-14:00 Registration
14:00-14:15 Opening Remarks
14:15-15:15 Keynote: Francis Collins, NIH, USA | TCGA: The Big Bang for Cancer Precision Medicine
15:15-16:15 Roundtable Discussion | The Cancer Genome Atlas: A model of cooperation
16:15-16:45 Refreshment Break
16:45-17:45 Meet the Editors Session
17:45-19:00 Welcome Drinks Reception
Friday, September 28, 2018
09:00-12:15 Session 1: Selected TCGA Project Vignettes
09:00-09:30 [INV01] Daniel Brat | Northwestern University, USA | Diffuse Gliomas: A Journey from molecular discovery to new diagnoses to practice guidelines
09:30-10:00 [INV02] Peter Laird, Van Andel Institute, USA
10:00-10:30 [INV03] W. Marston Linehan | NCI, NIH, USA | TCGA comprehensive molecular characterization of renal cell carcinoma
10.30-11:00 Refreshment Break
11:00-11:30 [INV04] Matthew Meyerson, Dana-Farber Cancer Institute & Harvard Medical School, USA | Aneuploidy: Chromosome arm level alterations across cancer
11:30-12:00 [INV05] Hui Shen, Van Andel Institute, USA
12:00-12:15 [ST01] Short talk selected from abstracts
12:15-12:25 Poster Teasers 1
12:25-13:30 Lunch
13:00-13:30 PerkinElmer Workshop
13:30-15:00 Poster Session 1
15:00-18:00 Session 2: Biological Discoveries through Multi-Omics Research
15:00-15:30 [INV06] Gordon Mills, Oregon Health and Science University, USA | Systems approach to rational combination therapy with PARP inhibitors
15:30-16:00 [INV07] Cory Abate-Shen, Columbia University, USA | Modeling prostate cancer in genetically-engineered mice in the post-genomic era
16:00-16:30 Refreshment Break
16:30-17:00 [INV08] Nuria Lopez-Bigas, IRB Barcelona, Spain
17:00-17:30 [INV09] Dvir Aran, UCSF, USA | Digitally deconvolving the tumor microenvironment
17:30-17:45 [ST02] Short talk selected from abstracts
17:45-18:00 [ST03] Short talk selected from abstracts
19:00-22:00 Meet the Speakers Dinner | Ticket holders only
Saturday, September 29, 2018
09:00-12:00 Session 3: Translational Insights from Multi-Omics Analyses
09:00-09:30 [INV10] Lillian Siu | University of Toronto, Canada | Multi-omic evaluation of biomarkers to predict response to immune checkpoint blockade: results from the Princess Margaret’s INSPIRE Study
09:30-10:00 [INV11] Alice Shaw, Harvard Medical School, USA
10:00-10:15 [ST04] Short talk selected from abstracts
10:15-10:30 [ST05] Short talk selected from abstracts
10:30-11:00 Refreshment Break
11:00-11:30 [INV12] Rebecca Fitzgerald, University of Cambridge, UK | Clinical insights from multi-omic studies on esophageal cancer
11:30-12:00 [INV13] Nicky McGranahan, The Francis Crick Institute, UK
12:00-12:15 [ST06] Short talk selected from abstracts
12:15-12:25 Poster Teasers 2
12:25-13:30 Lunch
13:30-15:00 Poster Session 2
15:00-18:00 Session 4: TCGA Pan Cancer Analyses
15:00-15:30 [INV14] Nikolaus Schultz, Memorial Sloan Kettering Cancer Center, USA
15:30-16:00 [INV15] Vesteinn Thorsson, Institute for Systems Biology, USA
16:00-16:30 [INV16] Katherine Hoadley, University of North Carolina, USA | Pancancer integrated molecular classification
16:30-17:00 [INV17] Li Ding, Washington University St. Louis, USA
17:00-17:30 [INV18] Carter Van Waes | NIDCD, NCI, USA | Genomic, pathway network, and immunologic features distinguishing squamous carcinomas
17:30-17:45 Closing Remarks
Copyright 2016 Elsevier Limited. Privacy | Terms | Cookies
Powered by Oxford Abstracts. Cookies are set by this site. To decline them or learn more, visit our Cookies page.